4.6 Review

International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors

Journal

PHARMACOLOGICAL REVIEWS
Volume 67, Issue 3, Pages 601-655

Publisher

AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
DOI: 10.1124/pr.114.010249

Keywords

-

Funding

  1. Academy of Finland
  2. Sigrid Juselius Foundation
  3. Finnish Foundation for Alcohol Studies
  4. Gedeon Richter
  5. GSK
  6. DFG [German Research Foundation] [GU434/6-1]
  7. Johnson Johnson
  8. Netherlands Organisation for Scientific Research (NWO)
  9. Abbott Laboratories
  10. Pfizer
  11. UCB Pharma
  12. Griffin Discoveries
  13. Wellcome Trust Grant [099156/Z/12/Z]
  14. European Cooperation in Science and Technology [Action BM0806]
  15. Ziarco Pharma Ltd.
  16. Wellcome Trust [099156/Z/12/Z] Funding Source: Wellcome Trust

Ask authors/readers for more resources

Histamine is a developmentally highly conserved autacoid found in most vertebrate tissues. Its physiological functions are mediated by four 7-transmembrane G protein-coupled receptors (H1R, H2R, H3R, H4R) that are all targets of pharmacological intervention. The receptors displaymolecular heterogeneity and constitutive activity. H1R antagonists are long known antiallergic and sedating drugs, whereas the H2R was identified in the 1970s and led to the development of H2R-antagonists that revolutionized stomach ulcer treatment. The crystal structure of ligand-bound H1R has rendered it possible to design new ligands with novel properties. The H3R is an autoreceptor and heteroreceptor providing negative feedback on histaminergic and inhibition on other neurons. A block of these actions promotes waking. The H4R occurs on immuncompetent cells and the development of anti-inflammatory drugs is anticipated.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available